Information Provided By:
Fly News Breaks for March 2, 2018
Mar 2, 2018 | 05:59 EDT
Deutsche Bank analyst Jack Hu says that while near-term pressure on shares of China Biologic Products, the stock is "cheap" at current levels. The analyst lowered his price target for the shares to $105 and $116 and keeps a Buy rating on China Biologic.
News For CBPO From the Last 2 Days
There are no results for your query CBPO